Although the combination of SK and TAM has been studied, including promotion of the anti-estrogen effect of TAM and modulation of PI3K/AKT pathway, the bypassing of cancer drug resistance by targeting the “weak point” of cancer has not been investigated further. This evidence concerns the gene AKT1 and cancer.